7th DIA Cardiac Safety Workshop in Japan

It will be a unique opportunity to learn of and discuss the current state and future directions of CV risk assessments and how to prepare for a new regulatory paradigm.

戻る Agenda

[Session 4] Cardiovascular Safety in Oncology Drug Development: Mechanisms of Cardiotoxicity

Session Chair(s)

Katsuyoshi Chiba, PhD

Senior Director and Head, Group III, Medicinal Safety Research Laboratories, R&D

Daiichi Sankyo Co., Ltd., Japan

Atsushi Sugiyama, MD, PhD

Professor and Chairman, Department of Pharmacology

Toho University Faculty of Medicine, Japan

Speaker(s)

Drug-Induced Cardiac Toxicity: Translating Non-Clinical Observations into Early Clinical Investigation

Atsuhiko T. Naito, MD, PhD

Toho University Faculty of Medicine, Japan

Associate Professor, Department of Pharmacology, School of Medicine

Development and Standardization of in vitro Contractility Method Using Human iPS Cell-Derived Cardiomyocytes

Yasunari Kanda, PhD

National Institute of Health Sciences, Japan

Head of Division of Pharmacology

Molecular Pathways and Pathophysiology of TKI Induced Cardiotoxicity

Junichi Ishida, MD, PhD

The University of Tokyo Hospital, Japan